Benjamin T Dake is of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 14,252 shares of AVTE, which is worth approximately $37,910. The most recent transaction as insider was on Nov 10, 2022, when has been sold 1,800 shares (Common Stock) at a price of $20.1 per share, resulting in proceeds of $36,180. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K
0% 3M change
1003.95% 12M change
Total Value Held $37,910

Benjamin T Dake Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 10 2022
SELL
Open market or private sale
$36,180 $20.1 p/Share
1,800 Reduced 100.0%
0 Common Stock
Nov 10 2022
BUY
Exercise of conversion of derivative security
$3,852 $2.14 p/Share
1,800 Added 50.0%
1,800 Common Stock
Nov 09 2022
SELL
Open market or private sale
$250,740 $17.91 p/Share
14,000 Reduced 100.0%
0 Common Stock
Nov 09 2022
BUY
Exercise of conversion of derivative security
$29,960 $2.14 p/Share
14,000 Added 50.0%
14,000 Common Stock
Nov 08 2022
SELL
Open market or private sale
$151,467 $18.09 p/Share
8,373 Reduced 100.0%
0 Common Stock
Nov 08 2022
BUY
Exercise of conversion of derivative security
$17,918 $2.14 p/Share
8,373 Added 50.0%
8,373 Common Stock
Nov 07 2022
SELL
Open market or private sale
$335,794 $19.05 p/Share
17,627 Reduced 100.0%
0 Common Stock
Nov 07 2022
BUY
Exercise of conversion of derivative security
$34,196 $1.94 p/Share
17,627 Added 50.0%
17,627 Common Stock
Oct 18 2022
SELL
Open market or private sale
$120,261 $21.08 p/Share
5,705 Reduced 100.0%
0 Common Stock
Oct 18 2022
BUY
Exercise of conversion of derivative security
$12,209 $2.14 p/Share
5,705 Added 50.0%
5,705 Common Stock
Oct 17 2022
SELL
Open market or private sale
$84,370 $20.16 p/Share
4,185 Reduced 100.0%
0 Common Stock
Oct 17 2022
BUY
Exercise of conversion of derivative security
$8,956 $2.14 p/Share
4,185 Added 50.0%
4,185 Common Stock
Oct 14 2022
SELL
Open market or private sale
$2,205 $20.05 p/Share
110 Reduced 100.0%
0 Common Stock
Oct 14 2022
BUY
Exercise of conversion of derivative security
$235 $2.14 p/Share
110 Added 50.0%
110 Common Stock
Oct 10 2022
SELL
Open market or private sale
$84,268 $17.01 p/Share
4,954 Reduced 100.0%
0 Common Stock
Oct 10 2022
BUY
Exercise of conversion of derivative security
$10,602 $2.14 p/Share
4,954 Added 50.0%
4,954 Common Stock
Oct 07 2022
SELL
Open market or private sale
$170,108 $16.17 p/Share
10,520 Reduced 100.0%
0 Common Stock
Oct 07 2022
BUY
Exercise of conversion of derivative security
$22,513 $2.14 p/Share
10,520 Added 50.0%
10,520 Common Stock
Oct 06 2022
SELL
Open market or private sale
$215,160 $16.5 p/Share
13,040 Reduced 100.0%
0 Common Stock
Oct 06 2022
BUY
Exercise of conversion of derivative security
$25,298 $1.94 p/Share
13,040 Added 50.0%
13,040 Common Stock
Sep 12 2022
SELL
Open market or private sale
$135,210 $17.98 p/Share
7,520 Reduced 100.0%
0 Common Stock
Sep 12 2022
BUY
Exercise of conversion of derivative security
$16,093 $2.14 p/Share
7,520 Added 50.0%
7,520 Common Stock
Sep 09 2022
SELL
Open market or private sale
$85,054 $18.02 p/Share
4,720 Reduced 100.0%
0 Common Stock
Sep 09 2022
BUY
Exercise of conversion of derivative security
$9,157 $1.94 p/Share
4,720 Added 50.0%
4,720 Common Stock
Sep 08 2022
SELL
Open market or private sale
$57,034 $18.28 p/Share
3,120 Reduced 100.0%
0 Common Stock
BTD

Benjamin T Dake

Waltham,, MA

Track Institutional and Insider Activities on AVTE

Follow Aerovate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

News

Receive news related to Aerovate Therapeutics, Inc.

Track Activities on AVTE